Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
For journalists & researchers

Press kit: everything you need to cite us.

Journalists, researchers, and content publishers: bios, photos, statistics, and quote requests. Same-day response on deadline requests received before noon ET.

Press contact

On deadline?

press@glpzoom.com

Same-day response before noon ET. Otherwise within 2 business days.

About GLPZoom

GLPZoom is an independent editorial and affiliate comparison platform for US telehealth programs covering GLP-1 weight management, ED, hair loss, mental health, and skincare treatments. We do not prescribe or dispense medications. Editorial rankings are never influenced by affiliate revenue. Affiliate relationships are disclosed inline on every page that includes them and aggregated on our affiliate disclosure.

Quick facts

36+

long-form articles

79+

Q&A entries

900+

state coverage pages

12

decision-support tools

17

clinical summaries

100%

primary-source cited

Editorial standards

  • Primary sources only. Clinical claims sourced from FDA labels, peer-reviewed trials (PMID-cited), and specialty-society guidelines.
  • "Last verified" dates. Every clinical page shows a verification date and a published correction log.
  • Affiliate transparency. Affiliate links are disclosed inline. Editorial picks cannot be purchased.
  • No fabricated reviewers. Pages display real reviewer credentials when available; otherwise organization-level editorial attribution is used.

Topics we comment on

GLP-1 medications

  • · Wegovy
  • · Ozempic
  • · Zepbound
  • · Mounjaro
  • · Saxenda
  • · Retatrutide
  • · Orforglipron

Telehealth platforms

  • · Ro
  • · Hims
  • · Sequence
  • · Calibrate
  • · NovoCare
  • · LillyDirect

Regulatory + access

  • · Insurance coverage patterns
  • · Compounded GLP-1 legality
  • · FDA decision calendar
  • · State prescribing legality
  • · Prior authorization timelines

Embed-ready statistics

Aggregated data we have compiled, free to cite with attribution to glpzoom.com:

  • · Compounded GLP-1 pricing benchmarks across pharmacies and platforms
  • · State-level telehealth GLP-1 prescribing legality (current verified date)
  • · Insurance carrier formulary coverage patterns for Wegovy and Zepbound
  • · Average prior-authorization approval timelines by carrier

Browse all datasets →

Reviewer panel

We do not list reviewers we have not verified. As clinician reviewers are onboarded, their credentials, photos, and review areas will appear at /about/reviewers. Our editorial integrity rule: no fabricated reviewer names ever.

Brand assets

Logo files (SVG and PNG), color tokens, and editorial photography available on request. Email press@glpzoom.com with publication and use case.

See also: Newsroom · Research + datasets · Editorial policy · Methodology · Corrections

We may earn a commission when you click links to partners. Affiliate disclosure.